Things that add significance to this outcome:
- This asset adaptable to many other forms of cancer apart from kidney (TLX250cdx) so expansion of asset pipeline huge
- GE partnership to push this asset (70 US billion $ company)
- break through designation and competitive edges that are attached to this designation
so much more
The world needs Telix
Ann: ZIRCON Ph III Imaging Study - Positive Top-Line Results, page-12
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.84 |
Change
-0.410(2.25%) |
Mkt cap ! $5.987B | |||
| Open | High | Low | Value | Volume |
| $18.02 | $18.07 | $17.79 | $18.80M | 1.035M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 313 | $17.83 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.85 | 220 | 2 |
View Market Depth
| Last trade - 11.00am 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$17.93 |
Change
-0.410 ( 1.55 %) |
||||
| Open | High | Low | Volume | ||
| $17.99 | $18.07 | $17.74 | 45553 | ||
| Last updated 11.19am 04/06/2024 ? | |||||
| TLX (ASX) Chart |